Fig. 3From: Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry studyResponder analysis HFMSE. Alluvial diagram to demonstrate changes in HMFSE over time for each cohort. Colors of columns indicate response groups according to changes in HFMSE score per time-period (baseline-m14, m14–m26, m26–m38). Lines between columns indicate the progression between time-periodsBack to article page